Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times